Drug metabolism in rat recombinant CYP2C13 assessed as (3Z,3'Z)-6,6'-(furan-2,5-diyl)bis(N'-hydroxynicotinimidamide) formation treated with DB868

Basic Information

ID: ALA3536075

Type: ADME

Description: Drug metabolism in rat recombinant CYP2C13 assessed as (3Z,3'Z)-6,6'-(furan-2,5-diyl)bis(N'-hydroxynicotinimidamide) formation treated with DB868

Format: BAO_0000019

Organism: Rattus norvegicus

Target: Cytochrome P450 2C13, male-specific(ALA3509596)

Document: ALA3525966

Drug metabolism in rat recombinant CYP2C13 assessed as (3Z,3'Z)-6,6'-(furan-2,5-diyl)bis(N'-hydroxynicotinimidamide) formation treated with DB868: 1

Associated Items: Associated Bioactivities Associated Compounds

Activity Charts

Bioactivity

Activity Types for Assay ALA3536075

Drug metabolism

Total(1)

Parent Molecular Weight	ALogP	Polar Surface Area
402.84	1.94	1.94

Parent Molecular Weight

ALogP

Polar Surface Area

402.84

1.94

Drug metabolism in rat recombinant CYP2C13 assessed as (3Z,3'Z)-6,6'-(furan-2,5-diyl)bis(N'-hydroxynicotinimidamide) formation treated with DB868

Basic Information

Activity Charts

Compound Summary